BioCardia, Inc. Operating Income Loss

• BioCardia, Inc. showed a decrease of -3.5% in Operating Income Loss from 2024 to 2025.
• This data is from BioCardia, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), BioCardia, Inc.'s Operating Income Loss has declined by 1,319.9%.
• Historical annual values: Fiscal year 2025: -$8.28 million | Fiscal year 2024: -$8.00 million | Fiscal year 2023: -$11.64 million | Fiscal year 2022: -$11.90 million | Fiscal year 2021: -$12.63 million | Fiscal year 2020: -$15.53 million | Fiscal year 2019: -$14.21 million | Fiscal year 2018: -$14.10 million | Fiscal year 2017: -$12.41 million | Fiscal year 2016: -$7.61 million | Fiscal year 2015: -$5.41 million | Fiscal year 2014: $231.0 thousand | Fiscal year 2013: $9.0 thousand | Fiscal year 2012: -$339.0 thousand | Fiscal year 2011: -$618.0 thousand | Fiscal year 2010: -$583.0 thousand.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026